EUVIMEDEUVIMED entdecken
Crossref

Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma

Andrew Hague

Carcinogenesis and Chemotherapy · 2024

DOI: 10.31579/2835-9216/017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis and Chemotherapy, 2024. Verfasst von Andrew Hague.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Use of the Cellsonic VIPP in the treatment of stage IV choriocarcinoma following two courses of chemotherapy appears to halt and reverse cancer markers and tumor volume in a 43-year-old male patient.

Zitieren

APA

Hague, A. (2024). Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma. Carcinogenesis and Chemotherapy. https://doi.org/10.31579/2835-9216/017

Vancouver

Hague A. Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma. Carcinogenesis and Chemotherapy. 2024. doi:10.31579/2835-9216/017

BibTeX
@article{Hague2024,
  author = {Hague, Andrew},
  title = {Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma},
  journal = {Carcinogenesis and Chemotherapy},
  year = {2024},
  doi = {10.31579/2835-9216/017}
}
Kostenlos starten →